Some 16s providers support download of FASTQ (raw data - BIG FILES). These can be processed thru other services (at the moment, Thryve and Biomesight offers free processing). The bacteria is determine by computer algorithms, which differs from lab to lab.
| Name | Percentage | |
|---|---|---|
| Thryve | 92.3% | |
| FASTQ processed thru both Thryve and BiomeSight | 92.3% | |
| CosmosId | 84.6% | |
| BiomeSight | 76.9% | |
| BiomeSightRdp | 74.4% | |
| Medivere | 71.8% | |
| uBiome | 71.8% | |
| SequentiaBiotech | 69.2% | |
| Thorne | 66.7% | |
| es-xenogene | 66.7% | |
| Microba | 48.7% | |
| Gut Zoomer (vibrant-wellness) | 41% | |
| AmericanGut | 38.5% | |
| GanzImmun Diagnostic A6 (cfu/gm) | 35.9% | |
| DayTwo | 30.8% | |
| GI360 Stool (UK) | 25.6% | |
| Biovis Microbiome Plus (cfu/g) | 23.1% | |
| Genova Gi Effects (cfu/g) | 23.1% | |
| Metagenomics Stool (De Meirleir) (16s Limited) | 20.5% | |
| NutriPATH | 20.5% | |
| Smart Gut (ubiome 16s - Limited Taxonomy) | 17.9% | |
| GanzImmun Diagnostics AG Befundbericht | 17.9% | |
| Diagnostic Solution GI-Map (cfu/gm) | 15.4% | |
| Medivere: Darn Magen Diagnostik (16s Limited) | 15.4% | |
| Medivere: Gesundsheitscheck Darm (16s Limited) | 15.4% | |
| Nordic Laboratories | 15.4% | |
| Viome (No objective measures) | 15.4% | |
| GI EcologiX (Invivo) | 12.8% | |
| InVitaLab (cfu/gm) | 12.8% | |
| Kyber Kompakt (cfu/g) | 12.8% | |
| Bioscreen (cfu/gm) | 12.8% | |
| Medivere: Darm Mikrobiom Stuhltest (16s limited) | 7.7% | |
| Verisana (cfu/ml) aka (kbe/ml) | 7.7% | |
| Genova Parasitology (cfu/g) | 5.1% |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.